Stay updated on Response to Immunotherapy in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Response to Immunotherapy in Lung Cancer Clinical Trial page.

Latest updates to the Response to Immunotherapy in Lung Cancer Clinical Trial page
- Check2 days agoChange DetectedAdded Gastric cancer and Bile Duct cancer to the conditions list and updated the page revision from v3.4.1 to v3.4.2.SummaryDifference0.1%

- Check9 days agoChange DetectedRevision: v3.4.1 was added and Revision: v3.4.0 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check17 days agoChange DetectedShow glossary option added and 45 study locations listed with updated site details and contacts (examples include Prospect Medical Hospital, Saint Luke's Institute – South, North Kansas City Hospital, etc.). Several previously listed locations and contacts were removed.SummaryDifference4%

- Check24 days agoChange DetectedThe new screenshot shows a similar page with a slightly different layout; the study's title, description, eligibility criteria, and contact details remain effectively the same.SummaryDifference0.0%

- Check31 days agoChange DetectedRevision: v3.3.4 replaces v3.3.3 on the page, indicating a backend/template update rather than changes to study content.SummaryDifference0.1%

- Check38 days agoChange DetectedNo additions or deletions were detected; the study details page content appears unchanged.SummaryDifference0.1%

Stay in the know with updates to Response to Immunotherapy in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Response to Immunotherapy in Lung Cancer Clinical Trial page.